// App-Quantinova.ai

1769 : Comparative Evaluation of Adverse Events Associated with Subcutaneous Infliximab (CT-P13 SC) and Intravenous Infliximab: A Real-world Analysis of Post-marketing Surveillance Data

Researchers

Presenter

  • Soohyun Lee

Principal Investigators

  • Xenofon Baraliakos

  • Diego Kyburz

  • Jérôme Avouac

  • Nick Barkham

Medical Centers

  • Rheumazentrum Ruhrgebiet, Herne, Germany

  • University Hospital Basel, Basel, Switzerland

  • University Paris-Sud, Paris, France

  • New Cross Hospital, Telford, United Kingdom

  • Celltrion Inc., Incheon, Republic of Korea

Locations

  • Germany

  • Switzerland

  • France

  • United Kingdom

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • Infliximab Biosimilar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved